TY  JOUR
TI  EVIDENCE BASE AND PROSPECTS OF APPLICATION IN CLINICAL PRACTICE  OF THE TYPE 2 SODIUM-GLUCOSE COTRANSPORTER INHIBITOR GROUP
KW  type 2 sodium-glucose cotransporter inhibitors
KW  SGLT2 inhibitors
KW  type 2 diabetes  mellitus
KW  heart failure
KW  chronic kidney disease
KW  non-alcoholic fatty liver disease
KW  metabolism
KW   cardioprotection
KW  nephroprotection
JO  Crimea Journal of Experimental and Clinical Medicine
AU  Ivancova, N.L.
AU  Platonova, P.A.
PY  2025
IS  15
PB  V.I. Vernadsky Crimean Federal University